Glycan Biosciences – Developing carbohydrate-based drugs

Glycan Biosciences is pioneering the development of a new class of compounds (Glycanics™) using its proprietary Chemistry platform and Biological screening matrix.

The Company has taken inspiration from naturally occurring carbohydrates known as GlycosAminoGlycans, or GAGs, that are found throughout the body. While GAGs have key roles in biology, their development as drugs has been prevented by their heterogeneity and lack of cost effective synthesis.

Glycan Biosciences’ Chemistry platform has, for the first time, enabled manufacture of compounds resembling GAGs that is scalable for industrial manufacturing. These compounds are chemically defined and active against specified protein drug targets, which make them ideal therapeutics for chronic inflammatory disease.